Drugs / HPC-A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02433483 | May 2015 → May 2017 | acute myeloid leukemia, myelodysplastic syndrome | St. Jude Children's Research Hospital | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPC-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02433483 ↗ |
| Modality | Cell therapy | “infusion of donor peripheral blood mononuclear cells” NCT02433483 ↗ |
| Route | Intravenous | “Given IV.” NCT02433483 ↗ |